Time to Prostate-specific Antigen Nadir and the Risk of Death From Prostate Cancer Following Radiation and Androgen Deprivation Therapy

To assess whether the time to prostate-specific antigen (PSA) nadir (TTN) has differential prognostic value in men who reach an undetectable vs detectable PSA nadir. Two hundred and four men from a prospective randomized controlled trial involving radiation therapy with or without 6 months of androg...

Full description

Bibliographic Details

Published in:	Urology (Ridgewood, N.J.) N.J.), 2019-04, Vol.126, p.145-151
Main Authors:	Pike, Luke R.G., Wu, Jing, Chen, Ming-Hui, Loffredo, Marian, Renshaw, Andrew A., Pfail, John, Kantoff, Philip W., D'Amico, Anthony V.
Format:	Article
Language:	English
Subjects:	Aged Androgen Antagonists - therapeutic use Combined Modality Therapy Follow-Up Studies Humans Male Prognosis Prospective Studies Prostate-Specific Antigen - blood Prostatic Neoplasms - blood Prostatic Neoplasms - mortality Prostatic Neoplasms - radiotherapy Prostatic Neoplasms - therapy Risk Assessment Time Factors
Citations:	Items that this one cites Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!